<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Leino AD</submitter><funding>American Foundation for Pharmaceutical Education</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><pagination>1141-1152</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9644239</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(17)</volume><pubmed_abstract>&lt;b>Background:&lt;/b> Volumetric absorptive microsampling may reduce the blood collection burden associated with therapeutic drug monitoring of immunosuppression to prevent organ transplant rejection. This work describes the development of a laboratory and analytical technique for quantifying tacrolimus and mycophenolic acid (MPA) from the Tasso-M20™ in human whole blood using bead-based impact-assisted extraction. &lt;b>Results:&lt;/b> The sampled blood volume was accurate with estimated volumes within &lt;2% of the expected 20 μl. Recovery using impact-assisted extraction was 73-87% for MPA and 100% for tacrolimus and was hematocrit-independent for both analytes. The LC-MS/MS assay is precise and accurate within the acceptance criteria of 15%. &lt;b>Conclusion:&lt;/b> The sampling and extraction procedure</pubmed_abstract><journal>Bioanalysis</journal><pubmed_title>Application of a new volumetric microsampling device for quantitative bioanalysis of immunosuppression.</pubmed_title><pmcid>PMC9644239</pmcid><funding_grant_id>P30CA046592</funding_grant_id><funding_grant_id>Pre-doctoral fellowship</funding_grant_id><pubmed_authors>Pai MP</pubmed_authors><pubmed_authors>Takyi-Williams J</pubmed_authors><pubmed_authors>Sun D</pubmed_authors><pubmed_authors>Wen B</pubmed_authors><pubmed_authors>Leino AD</pubmed_authors></additional><is_claimable>false</is_claimable><name>Application of a new volumetric microsampling device for quantitative bioanalysis of immunosuppression.</name><description>&lt;b>Background:&lt;/b> Volumetric absorptive microsampling may reduce the blood collection burden associated with therapeutic drug monitoring of immunosuppression to prevent organ transplant rejection. This work describes the development of a laboratory and analytical technique for quantifying tacrolimus and mycophenolic acid (MPA) from the Tasso-M20™ in human whole blood using bead-based impact-assisted extraction. &lt;b>Results:&lt;/b> The sampled blood volume was accurate with estimated volumes within &lt;2% of the expected 20 μl. Recovery using impact-assisted extraction was 73-87% for MPA and 100% for tacrolimus and was hematocrit-independent for both analytes. The LC-MS/MS assay is precise and accurate within the acceptance criteria of 15%. &lt;b>Conclusion:&lt;/b> The sampling and extraction procedure</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-05-18T12:59:05.324Z</modification><creation>2025-05-18T12:59:05.324Z</creation></dates><accession>S-EPMC9644239</accession><cross_references><pubmed>36208082</pubmed><doi>10.4155/bio-2022-0155</doi></cross_references></HashMap>